Example 5

In particular embodiments, a capsule is provided containing a pharmaceutical composition having fully solubilized, partially solubilized, or suspended progesterone comprising the components according to the formulations specified in Tables 8 and 9:

TABLE 8
Ingredient%mg/CapsuleFunction
Micronized30.77200.00Active
Progesterone
Medium Chain65.93428.55Carrier
Triglyceride
(MIGLYOL 812 or
equivalent)
Lauroyl polyoxyl-32-3.0019.50Suspending Agent
glycerides
(GELUCIRE 44/14 or
equivalent)
Butylated0.031.95Antioxidant
Hydroxytoluene
Total100650

TABLE 9
Ingredientmg/Capsule%Function
Progesterone200.0033.33Active
Medium Chain389.6064.93Solubilizing
TriglycerideAgent
(MIGLYOL 812 or
equivalent)
Lauroyl polyoxyl-32-10.001.67Non-ionic
glycerides (GELUCIRESurfactant
44/14 or equivalent)(suspending
agent)
Butylated0.400.07Antioxidant
Hydroxytoluene
Total600.00100.0

The pharmaceutical composition above can be prepared in accordance with the procedures noted in prior examples.

Free full text: Click here